@article{29833236572a496ab7fa76fb750ecc16,
title = "SARS-CoV-2 vaccination and phase 1 cancer clinical trials",
author = "Yap, {Timothy A.} and Siu, {Lillian L.} and Emiliano Calvo and Lolkema, {Martijn P.} and LoRusso, {Patricia M.} and Soria, {Jean Charles} and Ruth Plummer and {de Bono}, {Johann S.} and Josep Tabernero and Udai Banerji",
note = "Funding Information: We declare no competing interests related to the study, with full details of other competing interests listed in the appendix . TAY thanks the MD Anderson Cancer Center for support grant P30 CA016672 and the Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy at the MD Anderson Cancer Center for support grant 1U01 CA180964. RP, JSDB, and UB thank the Experimental Cancer Centre and National Institute of Health Biomedical Research Centre for infrastructural funding. ",
year = "2021",
month = mar,
doi = "10.1016/S1470-2045(21)00017-6",
language = "English (US)",
volume = "22",
pages = "298--301",
journal = "The lancet oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "3",
}